Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends approval of Teysuno for treatment of advanced gastric cancer

Dec. 23, 2010

EMA provides update on safety review for somatropin-containing medicines

Dec. 21, 2010

EMA's CHMP recommends approval of Esbriet for IPF

Dec. 21, 2010

Genentech provides update on Avastin for metastatic breast cancer

Dec. 20, 2010

EMA recommends approval of Xiapex for treatment of Dupuytren's contracture

Dec. 20, 2010

Novartis withdraws application to extend Zometa indication in E.U.

Dec. 17, 2010

E.C. approves sunitinib malate for treatment of pancreatic neuroendocrine tumors

Dec. 17, 2010

Alexza provides regulatory update for Staccato Loxapine

Dec. 10, 2010

European approval of Brilique for prevention of atherothrombotic events

Dec. 10, 2010

UCB updates progress from third quarter of 2010

Dec. 1, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...